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While the 2009 pandemic H1N1 virus has become established in the human population as a seasonal
inﬂuenza virus, continued adaptation may alter viral virulence. Here, we passaged a 2009 pandemic
H1N1 virus (A/Changchun/01/2009) in mice. Serial passage in mice generated viral variants with
increased virulence. Adapted variants displayed enhanced replication kinetics in vitro and vivo. Analysis
of the variants genomes revealed 6 amino acid changes in the PB1 (T296R), PA (I94V), HA (H3 num-
bering; N159D, D225G, and R226Q), and NP (D375N). Using reverse genetics, we found that a PB1-T296R
substitution found in all adapted viral variants enhanced viral replication kinetics in vitro and vivo,
increased viral polymerase activity in human cells, and was sufﬁcient for enhanced virulence of the 2009
pandemic H1N1 virus in mice. Therefore, we deﬁned a novel inﬂuenza pathogenic determinant, pro-
viding further insights into the pathogenesis of inﬂuenza viruses in mammals.
& 2015 Elsevier Inc. All rights reserved.Introduction
A novel swine-origin H1N1 reassortant inﬂuenza virus (2009
pH1N1) emerged in April of 2009 and caused the ﬁrst pandemic of
the 21st century (Garten et al., 2009). Although the pandemic
ended in August of 2010, the 2009 pH1N1 virus has continued to
circulate among humans as a seasonal inﬂuenza virus.
Prolonged circulation of 2009 pH1N1 viruses in the human
population may result in adaptive changes that impinge upon viral
virulence. Mice are a well-established mammalian model for
studying inﬂuenza A virus pathogenicity (Cheng et al., 2014a; Dengnstitute, 666 Liuyingxi St.,
6.
Institute, 666 Liuyingxi St.,
08.et al., 2015; Fan et al., 2009; Hatta et al., 2001; Jiao et al., 2008;
Manicassamy et al., 2010; Metreveli et al., 2014; Shinya et al.,
2004; Song et al., 2015; Tumpey et al., 2004, 2005). While mice are
not naturally infected with inﬂuenza viruses, inﬂuenza strains can
be experimentally adapted to mice (Chen et al., 2015; Yu et al.,
2015). Mouse-adapted inﬂuenza viruses have been shown to have
enhanced virulence (Chen et al., 2015; Cheng et al., 2014a; Sang
et al., 2015; Yu et al., 2015), possess an increased ability to infect
alveolar cells, and can cause lethal pneumonitis.
Here, we generated mutants of the 2009 pH1N1 virus through
serial lung-to-lung passages in mice. Serial passage of the 2009
pH1N1 virus in mice resulted in variant viruses that displayed a
marked increase in virulence. We identiﬁed a novel amino acid
change within the PB1 protein that is sufﬁcient for increased viral
pathogenicity for mice. In vitro and in vivo analyses demonstrated
that this substitution combination enhanced RNA polymerase
activity and viral replication. Therefore, we deﬁned a novel
Z. Yu et al. / Virology 486 (2015) 180–186 181inﬂuenza pathogenic determinant, providing further insights into
the pathogenesis of inﬂuenza viruses in mammals.Materials and methods
Ethics statement
The protocol of the study was conducted in accordance with
guidelines of animal welfare of World Organization for Animal
Health. All experimental protocol were approved by the Review
Board Military Veterinary Research Institute of the Academy of
Military Medical Sciences.
Facilities
Studies using the 2009 pandemic H1N1 inﬂuenza virus and
derivative mutants were conducted in a biosecurity level
3 laboratory approved by the Military Veterinary Research Insti-
tute of the Academy of Military Medical Sciences. All animal stu-
dies were approved by the Review Board of Military Veterinary
Research Institute of the Academy of Military Medical Sciences
(SYXK-2009-045).
Cells and virus
Madin-Darby canine kidney (MDCK) cells were cultured in
Dulbecco's Modiﬁed Eagle's Medium (DMEM) supplemented with
5% fetal calf serum (FCS), 100 IU/ml penicillin, 100 mg/ml strepto-
mycin, 2 mM glutamine. 293T cells were cultured in DMEM sup-
plemented with 10% FCS, 100 IU/ml penicillin, 100 mg/ml strep-
tomycin, and 2 mM glutamine. A549 cells were cultured in DMEM
supplemented with 2 mM glutamine, 10% FCS, 100 IU/ml penicillin,
and 100 mg/ml streptomycin. The 2009 pandemic H1N1 inﬂuenza
virus A/Changchun/01/2009 (abbreviated as XD), was obtained
from the Military Veterinary Research Institute of Academy of
Military Medical Sciences. Stock virus was grown in the allantoic
cavities of 10-day-old chicken eggs for 60 h at 37 °C, and aliquots
were stored at 80 °C until use. The GenBank accession numbers
corresponding to each of the eight XD viral gene segments are
JN032403–JN032410.
Adaptation of 2009 pandemic H1N1 inﬂuenza virus in mice
Three mouse-adapted variants of the XD virus were derived from
three independent series of sequential lung-to-lung passages of virus
in mice as described previously (Cheng et al., 2014a; Yu et al., 2015).
Brieﬂy, 4–6-week-old female BALB/c mice (Merial-Vital Laboratory
Animal Technology Co., Ltd., Beijing, China) were inoculated intra-
nasally with 50 μl of allantoic ﬂuid containing the XD H1N1 virus
under light isoﬂurane anesthesia. Lungs were harvested and homo-
genized 48 h after infection. The disrupted lung tissue was cen-
trifuged to remove debris and 50 μl of the supernatant was used to
inoculate the next naïve mouse in the series. Virus was passaged
mouse-to-mouse eighteen times in three independent lines. After
the eighteenth passage in each series of mice, viruses present in the
ﬁnal lung homogenates was cloned once by plaque puriﬁcation in
MDCK cells as described previously (Song et al., 2009). The cloned
viruses were independently ampliﬁed in the allantoic cavities of 10-
day-old chicken eggs for 60 hours at 37 °C to prepare virus stocks.
Three plaque-puriﬁed mouse-adapted variants of the original XD
virus were obtained for further characterization and named UIXD-
P18-1, UIXD-P18-2, and UIXD-P18-3.RNA isolation, PCR ampliﬁcation, and sequencing
Viral RNA was isolated from the allantoic ﬂuid of inoculated
eggs using the RNeasy Mini kit (QIAGEN, Germantown, MD)
according to the manufacturer's protocol as described previously
(Cheng et al., 2014b). Reverse transcription of viral RNA and sub-
sequent PCR were performed using primers speciﬁc for each gene
segment (sequences available upon request). PCR products were
puriﬁed using the QIAquick PCR puriﬁcation kit (QIAGEN, Ger-
mantown, MD) according to the manufacturer's protocol. Viral
gene segments were sequenced by the Beijing Genomics Institute
(Beijing, China). Sanger sequencing methodology was used to
sequence the PCR-ampliﬁed viral gene segments. DNA sequences
were analyzed and compared to the parental virus using
the Lasergene sequence analysis software package (DNASTAR,
Madison, WI).
Rescue of viruses by reverse genetics
We used an eight-plasmid reverse genetics system for virus res-
cue as described previously (Li et al., 2005). We inserted the cDNA
derived from XD or UIXD-P18-2 viral genes between the ribozyme
and polymerase I promoter sequence. A site-directed mutagenesis kit
(Invitrogen, www.invitrogen.com) was used to introduce speciﬁc
mutations in the viral genome. The plasmids used for transfection
were prepared using the QIAﬁlterTM Plasmid Midi kit (QIAGEN).
Recombinant viruses were rescued by transfection in 293 T cells as
previously described (Gao et al., 2009; Li et al., 2005), and propa-
gated in MDCK cells. All constructs were sequenced to ensure the
absence of unwanted mutations.
In vivo experiments
The 50% mouse lethal dose (MLD50) of the parental XD virus,
the three mouse-adapted isolates, and the recombinant viruses
was measured using groups of three female 4–6-week-old BALB/c
mice (Merial-Vital Laboratory Animal Technology Co., Ltd., Beijing,
China) as described previously (Cheng et al., 2014a). Mice were
intranasally inoculated with 50 μl of 10-fold serial dilutions of
each indicated inﬂuenza virus in PBS under isoﬂuorane sedation,
with doses ranging from 101–106 EID50. Survival and body weight
changes were recorded daily for 14 days post-infection (dpi).
Animals that showed signs of severe disease and weight loss
425% of their initial body weight were considered moribund and
were humanely sacriﬁced. MLD50 values were calculated by the
Reed–Muench method (Reed and Muench, 1938) after a 14-day
observation period and are expressed as EID50.
To evaluate the impact of individual amino acid substitutions
alone or in combination on morbidity and mortality, we inoculated
groups of ﬁve mice with 106 EID50 of the indicated inﬂuenza
viruses and recorded weight loss and mortality for 14 dpi. To
measure the replicative capacity of each virus in the lungs, cohorts
of mice were intranasally inoculated with 104 EID50 of each indi-
cated virus. On days 3 and 5 post-infection, three mice per group
were euthanized. The lungs were collected, homogenized, and
tissue debris was removed by low-speed centrifugation. Virus
titers of each sample were determined by endpoint titration in
eggs, and virus titers of each strain were expressed as mean log10
EID50/g7standard deviation (SD).
To evaluate the tropism and replication capacity of each virus
in vivo, we euthanized three mice on 3 days after inoculation with
106 EID50 of each indicated virus and harvested the lungs, nasal
turbinates (NT), brains, intestines, livers, spleens, and kidneys.
Organs were homogenized in 1 ml of PBS and viral titers in each of
the organs were determined by titration in chicken eggs. Titers
were calculated by the Reed–Muench method (Reed and Muench,
Z. Yu et al. / Virology 486 (2015) 180–1861821938) and expressed as mean log10EID50/g7SD. The limit of virus
detection was 0.75 log10 EID50/g. For calculation of the mean,
samples with a virus titer of o0.75 log10EID50/g were assigned a
value of 0.
Analysis of replication kinetics in vitro
MDCK cells and A549 cells were infected with the indicated
inﬂuenza viruses at a multiplicity of infection (MOI) of 0.01 TCID50
(50% tissue culture infectious dose)/cell. After incubation, the cells
were washed and overlaid with DMEM containing 2 mg/ml TPCK-
treated trypsin. Supernatants were collected 12, 24, 36, 48, 60, and
72 h after infection and stored at 80 °C. Virus titer was determined
by end-point titration in MDCK cells. Virus titers of each virus in
different time point were expressed as mean log10 TCID50/ml7SD.
Minigenome assay for polymerase activity
Polymerase activity was measured using a minigenome assay
as previously described (Cheng et al., 2014a; Song et al., 2011). In
brief, sub-conﬂuent monolayers of 293T cells were transfected
with a luciferase reporter plasmid (paviPolI-T-Luc) together with
the pTK-RL (Promega) and pcDNA3.1þplasmid constructs encod-
ing the polymerase genes PB2, PB1, PA, and NP using Lipofecta-
mine 2000 (Invitrogen) as recommended by the manufacturer.
pTK-RL expresses Renilla luciferase and was used as an internal
transfection control for the dual luciferase assay. After eight hours
incubation at 37 °C, the medium was replaced with DMEM con-
taining 10% FCS. Cell extracts were harvested 36 h post-
transfection and luciferase activity was assayed by using the
Luciferase assay system (Promega). The assay was standardized
against the Renilla luciferase activity. Experiments were per-
formed in triplicate.Fig. 1. Mouse-adapted pH1N1 viruses show increased virulence in mice and enhanced
taining 106 EID50 of mouse-adapted viruses (UIXD-P18-1, UIXD-P18-2 and UIXD-P18-3), o
group. Animals that lost more than 25% of their pre-infection weight were euthanize
percentage of the weight on the day of inoculation (day 0). The average of each group i
group. (B) MDCK cells were inoculated at a multiplicity of infection of 0.01 TCID50/cell w
UIXD-P18-2, or UIXD-P18-3). Supernatants were collected at the indicated time points
with 104 EID50 of the parental wild-type H1N1 virus (XD) or a mouse-adapted virus (UIX
3 and 5 days post-infection by EID50. Results are expressed as log10 EID50/g of tissue. The
EID50 of the parental wild-type H1N1 virus (XD) or a mouse-adapted virus (UIXD-P18-1,
turbinates (NT), brains, intestines, livers, spleens, and kidneys were titrated by EID50.
detection. In each panel, the average of three replicates is shown with error bars indica
UIXD-P18-2, and UIXD-P18-3 with XD respectively. **, °°, ††, indicate po0.01 when com
indicate po0.001 when comparing UIXD-P18-1, UIXD-P18-2, and UIXD-P18-3 with XDStatistical analysis
Data were analyzed by two-way analysis of variance using
GraphPad Prism version 5.00 (GraphPad Software, San Diego, CA,
USA). When a signiﬁcant effect was observed, pairwise compar-
isons were performed using the Bonferroni post-hoc test.Results
Generation of virulent mouse-adapted 2009 pH1N1 variants
Previous studies have shown that the novel 2009 pH1N1 virus
is nearly avirulent in mice (MLD50 of 6 log10 EID50 for A/California/
04/2009(H1N1)) (Itoh et al., 2009; Maines et al., 2009). In order to
generate mouse-adapted 2009 pH1N1 viral variants, we serially
passaged the 2009 pH1N1 XD virus in mice. Following serial
passage, three mouse-adapted variants were selected for further
characterization. At an infecting dose of 106 EID50, mice infected
with the mouse-adapted variants (UIXD-P18-1, UIXD-P18-2, and
UIXD-P18-3) displayed rapid weight loss and universally suc-
cumbed to infection by day 6 post-infection (Fig. 1A). In contrast,
4/5 mice infected with the parental XD virus recovered from the
infection (Fig. 1A).
Serial passage of the XD virus in mice produced variant viruses
with substantially increased virulence in mice as indicated by
marked reductions in MLD50 values. The XD virus MLD50 was 6.25
log10 EID50, whereas the MLD50 of the UIXD-P18-1, UIXD-P18-2,
and UIXD-P18-3 viruses were 3.75 log10 EID50, 3.25 log10 EID50,
and 4.25 log10 EID50, respectively (Table 1). These results show that
the serial passage of the XD virus in mice resulted in substantially
increased virulence.replicative capacity. (A) Mice (n¼5) were inoculated intranasally with 50 μl con-
r the parental wild-type H1N1 virus (XD). Mock-inoculated mice served as a control
d. Body weights of inoculated mice were recorded daily, and are presented as a
s shown. The numbers in the graphs indicate the proportion of surviving mice per
ith the parental wild-type H1N1 virus (XD) or a mouse-adapted virus (UIXD-P18-1,
and titrated in MDCK cells by TCID50. (C) Mice (n¼3) were inoculated intranasally
D-P18-1, UIXD-P18-2, or UIXD-P18-3). Viral loads in the lungs were determined at
dotted line indicates the limit of detection. (D) Mice (n¼3) were infected with 106
UIXD-P18-2, or UIXD-P18-3). On day 3 post-infection, viral loads in the lungs, nasal
Results are expressed as log10 EID50/g of tissue. The dotted indicates the limit of
ting the standard deviation. *, °, †, indicate po0.05 when comparing UIXD-P18-1,
paring UIXD-P18-1, UIXD-P18-2, and UIXD-P18-3 with XD respectively. ***, °°°, †††,
respectively. Statistical analysis was performed using a two-way ANOVA.
Table 1
MLD50 of wide-type virus, mouse-adapted variants, and recombinant viruses in
BALB/c mice and amino acid substitutions identiﬁed in indicated viruses.
Virusa PB1 PA HAb NP MLD50 (log10EID50)
296 94 159 225 226 375
XD T I N D R D 6.25
UIXD-P18-1 R V N G Q N 3.75
UIXD-P18-2 R V D G Q N 3.25
UIXD-P18-3 R V N D Q N 4.25
rXD T I N D R D 6
rUI182 R V D G Q N 3
rXD-PB1-296R R I N D R D 3
rXD-PA-94V T V N D R D 5
rXD-HA-159D/225G/
226Q
T I D G Q D 4.75
rXD-NP-375N T I N D R N 5
a XD, A/Changchun/01/2009 (H1N1); UIXD-P18-1, UIXD-P18-2, and UIXD-P18-
3, mouse-adapted variants; rXD, recombinant XD virus; rUI182, recombinant virus
carrying 8 genes from UIXD-P18-2; rXD-PB1-296R, recombinant virus carrying the
PB1-T296R substitution in the backbone of XD; rXD-PA-94V, recombinant virus
carrying the PA-I94V substitution in the backbone of XD; rXD-HA-159D/225G/
226Q, recombinant virus carrying the HA-N159D, D225G, and R226Q substitutions
in the backbone of XD; rXD-NP-375N, recombinant virus carrying the NP-D375N
substitution in the backbone of XD.
b H3 numbering.
Table 2
Web search for the amino acid changes observed in mouse-adapted H1N1 strains
generated in this study have been identiﬁed in 2009 pH1N1 isolates.
Segment Position Amino acid Frequency of substitution (no. of strains with
the substitution/total no. of strains)
PB1 296 R 0/ 4708
PA 94 V 0/ 4935
HA 159a D 7/10,346
225a G 87/10,346
226a Q 10,273/10,346
NP 375 N 8/5040
a H3 numbering.
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in vivo
We next evaluated the replicative ability of the parental XD
virus and mouse-adapted variants in MDCK cells (Fig. 1B). In vitro
growth kinetics revealed that the UIXD-P18-1, UIXD-P18-2, and
UIXD-P18-3 viruses grew faster and achieved higher titers than
the parental XD virus (Fig. 1B). UIXD-P18-2 grew to the highest
titer and yielded approximately 22-fold more virus than XD in
MDCK cells by 36 h post-inoculation (Fig. 1B). To determine if the
mouse-adapted H1N1 strains also replicate more efﬁciently than
wild type virus in vivo, we inoculated mice with 104 EID50 of each
virus and analyzed virus titers in the lungs on day 3 and 5 post-
infection (Fig. 1C). Each of the three mouse-adapted viral variants
was present at higher titers in the lungs of mice on day 3 and day 5
post-inoculation when compared to the parental XD virus (Fig. 1C).
These data show that the enhanced virulence of the mouse-
adapted H1N1 viruses correlates with increased viral replication
in vitro and in vivo.
The mouse-adapted viruses replicate to higher titers in respiratory
tissues and acquired the ability to replicate in the brain in mice
We then asked whether the increased virulence of the mouse-
adapted H1N1 strains was due to an expansion of the tropism of
the adapted variants. Mice were inoculated intranasally with 106
EID50 of the parental XD virus or one of the three mouse-adapted
variant viruses (UIXD-P18-1, UIXD-P18-2, or UIXD-P18-3). On day
3 post-infection, the lungs, nasal turbinates (NT), brains, intestines,
livers, spleens, and kidneys were collected and the viral load in
each tissue was determined (Fig. 1D). Virus was recovered from
the lungs and NT of mice inoculated with the parental XD virus,
but was not detected in any other organ tested (Fig. 1D). In con-
trast, virus from mice inoculated with each of the three mouse-
adapted H1N1 variants was recovered from the lungs and NT at
higher titers when compared to mice inoculated with the parental
XD virus and was also recovered from the brains of mice on day
3 post-infection (Fig. 1D). These data demonstrate that mouse-
adapted H1N1 variants replicate to higher titers in respiratory
tissues when compared to the parental XD virus and acquired the
ability to replicate to detectable levels in the brain.Sequence analysis
We sequenced the complete genome of the mouse-adapted
viruses to identify the mutations responsible for increased viru-
lence (Table 1). We focused our analysis on mutations that enco-
ded amino acid substitutions. Analysis of the variant virus gen-
omes revealed one amino acid change in the PB1 (T296R), one
amino acid change in the PA (I94V), three amino acid changes in
HA (H3 numbering; N159D, D225G, and R226Q), one amino acid
changes in the NP (D375N) (Table 1).
To investigate whether the amino acid changes observed in
mouse-adapted H1N1 strains generated in this study have been
identiﬁed in 2009 pandemic H1N1 isolates, we queried 2009
pH1N1 sequences deposited in the GenBank database (http://
www.ncbi.nlm.nih.gov/genomes/FLU/FLU.html). We identiﬁed
seven isolates (frequency of substitution is 7/10,346) possessing a
D residue at HA position 159 (H3 numbering), eighty-seven iso-
lates (frequency of substitution is 87/10,346) possessing a G resi-
due at HA position 225 (H3 numbering), ten thousand two hun-
dred and seventy-three isolates (frequency of substitution is
10,273/10,346) possessing a Q residue at HA position 226 (H3
numbering), and eight isolates (frequency of substitution is 8/
5040) possessing a N residue at NP position 375 (Table 2). The
PB1-T296R and PA-I94V substitutions were not identiﬁed in any
H1N1 strains deposited in GenBank (Table 2).
PB1-T296R substitution enhances viral replication in vitro
We used reverse genetics to generate stocks of the parental XD
virus (rXD), the most virulent mouse-adapted UIXD-P18-2 virus
(rUI182), and recombinant viruses incorporating one or more
amino acid substitutions identiﬁed in the UIXD-P18-2 virus to
assess the individual contribution of amino acid changes to the
increased virulence of the mouse-adapted 2009 pH1N1 virus. As
expected, the rUI182 virus grew to higher titers than the parental
rXD virus in MDCK cells (Fig. 2A) and A549 cells (Fig. 2B).
Recombinant viruses harboring a PA-I94V substitution, a NP-
D375N substitution, or the HA-N159D/D225G/R226Q substitu-
tions displayed modest enhancements in viral replication when
compared to the rXD parental virus in MDCK cells (Fig. 2A) and
A549 cells (Fig. 2B). In contrast, a recombinant virus possessing the
PB1-T296R substitution phenocopied the mouse-adapted rUI182
virus, suggesting that an arginine residue at PB1 position 296 was
sufﬁcient for increased replicative capacity in MDCK cells (Fig. 2A)
and A549 cells (Fig. 2B).
PB1-T296R substitution enhance viral replication in vivo
We then evaluated the in vivo replicative capacity of each
recombinant virus. Mice were inoculated with 104 EID50 of each
virus and virus titers in the lungs were measured on days 3 and 5
post-infection (Fig. 3A). The rUI182 mouse-adapted virus
Fig. 2. Effects of amino acid substitutions on in vitro replication kinetics. The parental XD virus and recombinant viruses possessing one or more of the amino acid
substitutions identiﬁed in mouse-adapted viral variants were generated by reverse genetics. (A) MDCK cells or (B) A549 cells were inoculated at a multiplicity of infection of
0.01 TCID50/cell with rXD, rUI182, rXD-PB1-296R, rXD-PA-94V, rXD-HA-159D/225G/226Q, or rXD-NP-375N. Supernatants were collected at the indicated time points and
titrated in MDCK cells by TCID50. In each panel, the average of three replicates is shown with error bars indicating the standard deviation. *, °, †, #, &, indicate po0.05 when
comparing rUI182, rXD-PB1-296R, rXD-PA-94V, rXD-HA-159D/225G/226Q, and rXD-NP-375N with rXD respectively. **, °°, ††, ##, &&, indicate po0.01 when comparing
rUI182, rXD-PB1-296R, rXD-PA-94V, rXD-HA-159D/225G/226Q, and rXD-NP-375N with rXD respectively. ***, °°°, †††,###, &&&, indicate po0.001 when comparing rUI182,
rXD-PB1-296R, rXD-PA-94V, rXD-HA-159D/225G/226Q, and rXD-NP-375N with rXD respectively. Statistical analysis was performed using a two-way ANOVA.
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5 post-inoculation (Fig. 3A). A recombinant virus incorporating the
PB1-T296R substitution alone replicated to titers comparable to
the rUI182 mouse-adapted virus, suggesting that PB1-T296R was
primarily responsible for the increased in vivo replicative capacity
of the mouse-adapted virus (Fig. 3A). In contrast, recombinant
viruses harboring a PA-I94V substitution, HA-N159D/D225G/
R226Q substitutions, or a NP-D375N substitution displayed only
modestly increased lung viral titers when compared to the par-
ental rXD virus (Fig. 3A). These data show that a PB1-T296R sub-
stitution increases the replicative capacity of the parental XD virus
in vivo.
PB1-T296R substitution enhance virulence and expand the tropism of
2009 pandemic H1N1 virus in mice
Cohorts of mice were infected with 106 EID50 of the recombi-
nant parental virus rXD, the recombinant mouse-adapted virus
rUI182, or a recombinant virus possessing one or more of the
amino acid substitutions identiﬁed in the mouse-adapted virus.
Infected mice were followed for 14 days to evaluate weight loss
and survival. Mice inoculated with rXD, rXD-PA-94V, rXD-HA-
159D/225G/226Q, or rXD-NP-375N showed modest body weight
loss and partial lethality of the infected cohort (Fig. 3B). In con-
trast, mice infected with rUI182 and rXD-PB1-296R rapidly lost
weight and succumbed to infection by day 4 post-infection
(Fig. 3B). We determined the rXD virus MLD50 was 6 log10 EID50,
and the MLD50 of the rUI182, rXD-PB1-296R, rXD-PA-94V, rXD-
HA-159D/225G/226Q, and rXD-NP-375N viruses were 3 log10
EID50, 3 log10 EID50, 5 log10 EID50, 4.75 log10 EID50, and 5 log10
EID50, respectively (Table 1). The mouse lethal doses (MLD50) of
the rXD-PB1-296R were reduced 1000-fold compared to the par-
ental virus. These data demonstrate that the PB1-T296R substitu-
tion alone was sufﬁcient to confer increased virulence to the
parental rXD virus.
We next sought to identify the amino acid substitutions that
conferred expanded tissue tropism to the mouse-adapted virus.
Mice were inoculated intranasally with 106 EID50 of rXD, rUI182,
rXD-PB1-296R, rXD-PA-94V, rXD-HA-159D/225G/226Q, and rXD-
NP-375N, and virus replication in the lungs, nasal turbinates (NT),
brains, intestines, livers, spleens, and kidneys of infected animals
was determined on day 3 post-infection (Fig. 3C). The recombinant
virus possessing a PB1-T296R substitution replicated to higher
titers in the lungs and NT when compared to the rXD and the
other recombinant viruses and was present at levels comparable
to the mouse-adapted rUI182 virus (Fig. 3C). Additionally, the
recombinant virus possessing a PB1-T296R substitution was
recovered from the brain, indicating the PB1-T296R substitution issufﬁcient to confer extrapulmonary replication in the brain
(Fig. 3C). Taken together, these data show that the PB1-T296R
substitution enhances virulence and expands the tropism of 2009
pandemic H1N1 virus in mice.
PB1-T296R substitution enhances viral polymerase activity
The enhanced replication of viruses possessing PB1-T296R
substitution in vitro and in vivo suggested that this amino acid
substitution could impact viral polymerase activity. We applied a
mini-genome reporter assay to assess the impact of the PB1-
T296R, PA-I94V, or NP-D375N substitutions on the transcription
and replication of viral RNAs (vRNAs) in human 293T cells. The
PB1-T296R substitution increased polymerase activity approxi-
mately 1.8-fold (Fig. 4). In contrast, the NP-D375N substitution did
not increase polymerase activity (Fig. 4). It is worth noting that the
PA-I94V substitution also increased polymerase activity approxi-
mately 2.7-fold (Fig. 4). Because we do not exclude that the
increase of polymerase activity is caused by expression level dif-
ference of PB1, this result suggests that the enhanced replication of
viruses harboring PB1-T296R substitution in vitro and in vivo may
be in part due to enhanced viral polymerase activity.Discussion
In 2009, a novel H1N1 inﬂuenza A virus emerged and caused a
pandemic. Continuing evolution of circulating 2009 pH1N1 viruses
in the human population may additionally result in changes to
viral virulence. The speciﬁc amino acid substitutions that are likely
to enhance virulence in mammals are not well known. Although
amino acid substitutions in the avian (PB2 and PA)/human (PB1)
RNA-dependent RNA polymerase (RDRP) that enhance the repli-
cative capacity and transmission of 2009 pH1N1 viruses have been
reported previously (e.g., PB2-G590S/Q591R) (Mehle and Doudna,
2009; Yamada et al., 2010; Zhang et al., 2012), additional evolu-
tionary changes will likely be acquired as the virus adapts to
humans.
Serial passage of inﬂuenza viruses in animals has been widely
used to identify adaptive mutations that result in enhanced viral
pathogenicity (Gabriel et al., 2005; Hensley et al., 2009). For
example, an amino acid substitution at position 225 of the HA
protein has been identiﬁed in 2009 pH1N1 isolates from severely
ill patients, though its role in viral virulence is uncertain (Chen et
al., 2010). PB2-E158G is a novel pathogenic determinant of inﬂu-
enza A viruses in the mouse model in a previous study(Zhou et al.,
2011). Remarkably, PB2-E158G substitutions also altered the
pathotypes of two avian H5 viruses in mice, indicating that this
Fig. 3. Effects of amino acid substitutions on in vivo replication kinetics, virulence,
and tropism. The parental XD virus and recombinant viruses possessing one or
more of the amino acid substitutions identiﬁed in mouse-adapted viral variants
were generated by reverse genetics. (A) Mice (n¼6) were inoculated intranasally
with 104 EID50 of the indicated virus. Viral loads in the lungs of infected mice (n¼3/
time point) were determined at 3 and 5 dpi in eggs by EID50. Results are expressed
as log10 EID50/g of tissue. The dotted indicates the lower limit of detection of
infectious virus. (B) Mice (n¼5) were infected with 106 EID50 of the indicated virus
and followed for weight loss. The numbers in the graphs indicated the numbers of
surviving mice per group. (C) Mice (n¼3) were inoculated intranasally with 106
EID50 of the indicated virus. Viral loads in the lungs, nasal turbinates (NT), brains,
intestines, livers, spleens, and kidneys were determined at 3 dpi in eggs by EID50.
The dotted indicates the lower limit of detection of infectious virus. In each panel,
the average of three replicates is shown with error bars indicating the standard
deviation. *, °, †, #, &, indicate po0.05 when comparing rUI182, rXD-PB1-296R,
rXD-PA-94V, rXD-HA-159D/225G/226Q, and rXD-NP-375N with rXD respectively.
**, °°, ††, ##, &&, indicate po0.01 when comparing rUI182, rXD-PB1-296R, rXD-PA-
94V, rXD-HA-159D/225G/226Q, and rXD-NP-375N with rXD respectively. ***, °°°,
†††,###, &&&, indicate po0.001 when comparing rUI182, rXD-PB1-296R, rXD-PA-
94V, rXD-HA-159D/225G/226Q, and rXD-NP-375N with rXD respectively. Statistical
analysis was performed using a two-way ANOVA.
Fig. 4. Viral polymerase activity of RNP complexes. 293T cells were transfected
with a luciferase reporter plasmid (paviPolI-T-Luc) that expresses a negative-sense
virus-like RNA encoding a destabilized ﬁreﬂy luciferase enzyme, and one plasmid
for each of the proteins in the polymerase complex (NP, PB1, PB2, and PA). Cells
were also cotransfected with a Renilla luciferase expression plasmid to control for
transfection efﬁciency. Thirty-six hours post-transfection, ﬁreﬂy and Renilla luci-
ferase levels were measured, and Renilla expression was used to normalize the
data. The averages of triplicate experiments are shown. Error bars represent the
standard deviation (SD).
Z. Yu et al. / Virology 486 (2015) 180–186 185residue impacts genetically divergent inﬂuenza A viruses (Zhou
et al., 2011). In addition, some naturally occurring mutations in the
PA gene are contributors to increased virulence of 2009 pandemic
inﬂuenza virus in mice (Sun et al., 2014).
Our data demonstrates that a single amino acid substitution in
the PB1 protein (T296R) was sufﬁcient to confer increased viral
virulence to the 2009 pH1N1 virus. The enhanced replication of
viruses possessing PB1-T296R substitution in vitro and in vivo
suggested that this amino acid substitution could impact viral
polymerase activity. Consistent with enhanced growth kinetics
in vivo and in vitro, the PB1-T296R amino acid substitution
increased polymerase activity in a luciferase-based mini genome
assay (Fig. 4). Taken together, our data show that the PB1-T296Rsubstitution alone enhances viral virulence, polymerase activity
and viral replication kinetics of a pH1N1 virus.
Adaptation is considered to drive evolution by conferring
mutations that enhance viral ﬁtness. In our study, we found that
an amino acid substitution (PB1-T296R) was the primary virulence
determinant responsible for the increased pathogenicity of 2009
pH1N1 virus in mice. Since the 2009 pH1N1 virus containing
PB1-T296R replicated efﬁciently in mammalian cells and the RDRP
activity of this virus was enhanced in human kidney cells, we
speculate that PB1-T296R substitution might enhance 2009
pH1N1 replication in other mammalian species, although addi-
tional work in other animal models, such as ferrets or primates,
are needed to better assess the impact of the PB1-T296R sub-
stitution on pH1N1 virulence in humans. These ﬁndings deﬁne
PB1-T296R as a pH1N1 virulence determinant and emphasize the
importance of surveillance efforts to track the emergence of viral
variants with amino acid substitutions that are known to affect
viral virulence in animal models. Ultimately, deﬁning the mole-
cular features associated with altered virulence may facilitate the
early recognition of variant viruses with epidemic potential.Acknowledgments
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